21.600
−0,46%
2026-10-13
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +15.3% | +52.7% | 2 / 3 | +66.6% | -1.50 pp | -0.29 pp | +25.7% | 0.43 | 5.17 | 717 | +66,6% | 4,7 | +15,3% | 5.17 | 6.28 | −17,6% |
| Pts | 0 | 12 | 8 | 12 | 4 | 4 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 21.600 (close price on 2026-10-13)EPS (TTM): 4.174
Financial charts
1.Revenue & growth
VND bn717Q2/26
1.Revenue & growth
VND bn717Q2/26
2.Profit & growth
VND bn4,69Q2/26
3.Profit mix (Penman)
VND bn33,3Q2/26
4.Margins & cost structure
%9.8%Q2/26
5.Returns & cash cycle
% · days21.5%Q2/26
6.Earnings quality & cash
VND bn105Q2/26
7.Asset structure
VND bn329Q2/26
8.Funding & debt health
VND bn · times329Q2/26
9.Revenue backlog
VND bn4,31Q2/26
10.Valuation
times · %5,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %729Q2/26
Adjusted EPS growth, latest quarter
15.3%
Average adjusted EPS growth, 3 quarters
52.7%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26